200
Participants
Start Date
November 7, 2025
Primary Completion Date
November 30, 2028
Study Completion Date
November 30, 2028
No intervention
This is a non-interventional study
Peking University First Hospital, Beijing
Peking University Third Hospital, Beijing
Peking Union Medical College Hospital, Beijing
The Second Affiliated Hospital of Harbin Medical University, Harbin
Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing
The First Affiliated Hospital With NanJing Medical University(JiangSu Province Hospital), Nanjing
The First Affiliated Hospital Of Soochow University, Suzhou
The First Affiliated Hospital Of USTC (AnHui Provincial Hospital), Hefei
TianJin Chest Hospital, Tianjin
The Second Affiliated Hospital ZheJiang University School Of Medicine, Hangzhou
Fuzhou University Provincial Affiliated Hospital, Fuzhou
ShanTou Central Hospital, Shantou
The University Of Hong Kong-ShenZhen Hospital, Shenzhen
West China Hospital of Sichuan University, Chengdu
The Second Affiliated Hospital of Xi 'an Jiaotong University, Xi'an
The First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an
The Second Hospital of Hebei Medical University, Shijiazhuang
Second Hospital Of ShanXi Medical University, Taiyuan
Lead Sponsor
Takeda
INDUSTRY